Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
Quick Stats
May 18, 202652.2
AI Score
HOLD0.55
Volume Ratio
May 11, 2026
Next Earnings
17
+ve Days (30d)
12
-ve Days (30d)
AGEN Stock Summary
Last updated May 18, 2026
AGEN is currently trading at $3.175, positioned below its 200-day moving average of $3.88, suggesting bearish momentum. The stock has a 52-week range of $2.71 to $7.34.
Technical Analysis: The 50-day moving average stands at $3.77, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 39.07, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.243, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates AGEN at 52.2/100 with a HOLD recommendation.
AGEN (Agenus Inc.) Indicators
Last updated May 18, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 39.07 |
| CMF (20) | -0.243 |
| ROC (10) | -19.776 |
| ADX (14) | 17.893 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.127 |
| AROONOSC (14) | -28.571 |
| WILLAMS %R (14) | -97.664 |
| MFI (14) | 39.466 |
AGEN Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
AGEN Price vs Max Options Open Interest
AGEN Max Change In Options Open Interest
AGEN Options - Sort by Max open Interest (near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
AGEN Daily Out of Money Options - Sort by Max open Interest (near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
AGEN Daily In the Money Options - Sort by Max open Interest (near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
AGEN Most Active Options by Volume(near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Agenus Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
AGEN Moving Averages Analysis
AGEN (Agenus Inc.) Simple Moving Averages
Moving Averages are last updated May 18, 2026
| Days | MA |
|---|---|
| 10 | 3.62 |
| 20 | 3.76 |
| 30 | 3.98 |
| 50 | 3.77 |
| 100 | 3.52 |
| 200 | 3.88 |
AGEN Fundamental Analysis
| P/E (Forward) | 1.7364 |
| P/E (Trailing) | 1.7463 |
| Market Cap ($) | 149.1 million |
| Earnings/Share ($) | 2.05 |
| Net Proft Margin (%) | 0.5216 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0.5 |
| EPS Estimate Next Year ($) | -2.3 |
| WallStreet Target Price ($) | 15.5 |
| Most Recent Quarter |